Scientific Advisory Committee

BlumenthalJames A Blumenthal, PhD, ABPP
Duke University Medical Center
Durham, NC
Term: 2016 - 2020

James A. Blumenthal, PhD ABPP is JP Gibbons Professor of Psychiatry and Behavioral Sciences at Duke University Medical Center. He received his Ph.D. from the University of Washington in Clinical Psychology and is board certified from the American Board of Professional Psychology. Dr. Blumenthal is the recipient of several awards including an honorary doctorate from Uppsala University, the Outstanding Contributions to Health Psychology Award from the American Psychological Association, the Bakken Pioneer Award from the Cleveland Clinic Heart-Brain Institute, the Michael L. Pollock Established Investigator Award from the American Association of Cardiac and Pulmonary Rehabilitation and the Dodson Award for Excellence in Research in Adult Development and Aging.  He is a founding fellow of the American Association of Cardiopulmonary Rehabilitation and holds fellowship status in the American Psychological Association, the Society of Behavioral Medicine, and the Academy of Behavioral Medicine Research.  He is former President of the American Psychosomatic Society and the Society of Health Psychology of the American Psychological Association.  

Dr. Blumenthal has served as principal investigator from Duke site for the multi-center clinical trial known as ENRICHD, a study of cognitive behavior therapy in the treatment of depression and low social support in post-myocardial infarction patients.  He also has led a number of other NIH-sponsored clinical trials for patients with coronary heart disease and mental stress-induced myocardial ischemia (Smart Heart), patients engaged in cardiac rehabilitation (ENHANCED), patients with hypertension (ENCORE and TRIUMPH), patients with depression (SMILE and UPBEAT), and patients with pulmonary disease (INSPIRE).   His current projects focus on lifestyle interventions for patients with mild cognitive impairments (ENLIGHTEN), and exercise and anxiolytic medications for anxious patients with ischemic heart disease (UNWIND).

Diane M Canova, JD
American Legacy Foundation
Washington, DC
Term: 2016 - 2020

Diane Canova, JD, is a long time prevention and health policy expert and advocate who most recently served as senior vice president for government affairs for the American Legacy Foundation in Washington, DC.  Diane’s work at Legacy focused on efforts to influence federal tobacco policy and regulatory decision-making to ensure comprehensive FDA authority over all tobacco products.  Diane previously served as vice president for policy and programs for Partnership for Prevention where she led efforts to include preventive services in the Affordable Care Act, expansion of Medicare and Medicaid tobacco cessation coverage and development of “Action to Quit” online tobacco cessation resources.  Diane’s leadership in the public health sector also included serving as vice president of public policy for the American Heart Association and director of government relations for the American Red Cross.

Catherine Christie, PhD, RD, LD/N
University of North Florida
Jacksonville, FL

Term: 2016-2020

Dr. Catherine Christie is Associate Dean, Professor, and Graduate Nutrition Program Director in the Brooks College of Health at the University of North Florida. A Registered Dietitian, Fellow of the Academy of Nutrition and Dietetics and Fellow of the Preventative Cardiovascular Nurses Association, Dr. Christie earned her degrees from Florida State University including a Ph.D. and M.S. in Food and Nutrition. Before coming to UNF in 2011, she was a clinical endocrine dietitian, private practice nutrition business owner and practitioner, and served as Vice President of Continuing Education for a continuing education provider for health professionals, writing and delivering six hour continuing education courses on various aspects of nutrition to health professionals. Since coming to UNF, she served as the Master’s Dietetic Internship Director, Nutrition Program Director, Chair of the Department of Nutrition and Dietetics, and now Associate Dean of the Brooks College of Health. Her research has focused on overweight and obesity prevention and treatment, nutrition in chronic disease prevention and treatment, and inter-professional collaboration in education and health care. 

Dr. Christie is a Past President of the Florida Academy of Nutrition and Dietetics and currently serves on the Board of Directors of the national Academy of Nutrition and Dietetics, the world’s largest organization of food and nutrition professionals. She served for nine years with six years as Chairman of the Dietetics and Nutrition Council which regulates the nutrition profession in the state of Florida. Dr. Christie is co-author of four books including The Latino Food Lover’s Glossary, Fat is Not Your Fate, Eat to Stay Young and I’d Kill for a Cookie, multiple book chapters and peer reviewed journal articles. She is also Editor of the Manual of Medical Nutrition Therapy which is updated and published by the Florida Academy of Nutrition and Dietetics yearly. Dr. Christie has been active in service to community based programs and agencies, currently serving on the Board of the American Heart Association Jacksonville Affiliate and as Treasurer of the North Florida Area Health Education Centers. She is the recipient of numerous awards including Florida’s Distinguished Dietitian, Florida Dietetic Association Outstanding Service Award, the American Dietetic Association Outstanding Dietetic Educator Award, Florida Academy of Nutrition and Dietetics President’s Mentor Award and the Academy of Nutrition and the Dietetics Excellence in Practice Award for Education in Nutrition and Dietetics.

Rhonda Cooper-DeHoff 
University of Florida
Gainesville, FL
Term: 2016-2020

Dr. Cooper-DeHoff is Associate Professor in the Department of Pharmacotherapy and Translational Research, College of Pharmacy and Division of Cardiovascular Medicine, College of Medicine, and Associate Director of the Center for Pharmacogenomics at the University of Florida in Gainesville, Florida. She earned her Pharm D degree from the University of California at San Francisco, School of Pharmacy in 1986 and completed a clinical residency there in 1987. Subsequently, in 2007, she graduated from the University of Florida with a master’s degree in medical sciences, with an emphasis in clinical and translational research. Dr. Cooper-DeHoff’s research interests include hypertension, metabolic syndrome and diabetes, coronary artery disease and pharmacogenetics and most recently, precision medicine. She is an M-PI on the NIH funded grant entitled Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) and previously held an NIH-funded Career Development Award (K23) entitled “Metabolic Effects of Antihypertensive Drugs” and was co-investigator on an NIH funded pharmacogenetics grant. She was also an investigator of the International Verapamil Trandolapril Study (INVEST) which evaluated hypertension treatments in elderly coronary artery disease patients. She is also a member of the UF IRB and serves as a resource on human subjects research and ethics for the College of Pharmacy.

William L Haskell, PhD
Stanford University
Palo Alto, CA
Term: 2016-2020

​Dr. Haskell is Professor of Medicine (active emeritus) in the Stanford Prevention Research Center and the Division of Cardiovascular Medicine at Stanford University School of Medicine. His doctoral training was in exercise physiology with postdoctoral training in chronic disease epidemiology. He has been a member of the Stanford Medical School faculty for the past 40 years with primary interests in applied and clinical research in preventive cardiology, cardiac rehabilitation, the role physical activity in chronic disease prevention and successful aging. He has been a principal investigator on numerous single and multi-center clinical trials investigating chronic disease prevention or management. Of particular interest has been the role of habitual physical activity and related health behaviors in metabolic and hemodynamic factors contributing to the development of atherothrombotic vascular disease and diabetes mellitus. 

Current research involves collaborations with engineers at MIT and Northeastern University in the development of wireless sensors and common mobile phones for the continuous monitoring of health behaviors and environmental exposures in free-living populations. He has served on numerous national and international panels responsible for developing guidelines for physical activity and public health, preventive cardiology and cardiac rehabilitation. He was chair of the Physical Activity Guidelines Advisory Committee for the US Department of Health and Human Services. This Committee documented the scientific basis for the 2008 Physical Activity Guidelines for Americans. During 2008-2010 he was a scientific adviser to the World Health Organization for the development of WHO Global Recommendations on Physical Activity for Health (2010) and to the United Kingdom Health Ministries for the development of United Kingdom Physical Activity and Sedentary Behavior Guidelines (2011). Recently he was Chair of the International Review Panel for the Evaluation of Exercise and Sports Sciences in the Nordic Countries and co-chair of the expert panel on physical activity and physical fitness for development of the PhenX toolkit for the NIH sponsored Genes and Exposures Initiative (GEI).

Martha N Hill, RN, PhD
Johns Hopkins School of Nursing
Baltimore, MD
Term: 2016-2020

Dr. Martha Hill served as Dean of the Johns Hopkins University School of Nursing from 2001 until early 2014 and has been a member of the faculty since the School was established in 1983. As an educator, she is known for her mentorship of students and junior faculty members; as a researcher, for her investigations in preventing and treating hypertension and its complications, particularly among young, urban African-American men. Her expertise in community-based participatory research focuses on the integration of multi-professional health care to improve treatment and outcomes for vulnerable and underserved populations. She has been an active investigator, mentor, and consultant on numerous National Institutes of Health-funded clinical trials and is recognized around the globe for her research projects including “Comprehensive HBP Care for Young Urban Black Men,” “Barriers to HBP Care and Control in Black South Africans,” and “Research Training in Health Disparities in Underserved Populations.” Dr. Hill is a member of the Institute of Medicine and serves on the IOM Council and the Board of Directors of Research! America. From 1997-1998, Dr. Hill served as President of the American Heart Association, the first of two non-physicians to be named to that position. She is a professor of nursing, medicine, and public health. 

Ronald M Krauss, MD
Lawrence Berkeley National Laboratory
 Berkeley, CA
Term: 2016-2020

Ronald M. Krauss, M.D., is Senior Scientist and Director of Atherosclerosis Research at Children’s Hospital Oakland Research Institute, Adjunct Professor in the Department of Medicine at UCSF and in the Department of Nutritional Sciences at UC Berkeley, and Guest Senior Scientist in the Department of Genome Sciences of Lawrence Berkeley National Laboratory. He received his undergraduate and medical degrees from Harvard University with honors and served his internship and residency on the Harvard Medical Service of Boston City Hospital.  He then joined the staff of the National Heart, Lung, and Blood Institute in Bethesda, Maryland, first as Clinical Associate and then as Senior Investigator in the Molecular Disease Branch. Dr. Krauss is board-certified in internal medicine, endocrinology and metabolism, and is a member of the American Society for Clinical Investigation, a Fellow of the American Society of Nutrition and the American Heart Association (AHA), and a Distinguished Fellow of the International Atherosclerosis Society. He a member of the U.S. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, founder and past Chair of the AHA Council on Nutrition, Physical Activity, and Metabolism, and a National Spokesperson for the AHA. Dr. Krauss has also served on both the Committee on Dietary Recommended Intakes for Macronutrients and the Committee on Biomarkers of Chronic Disease of the Institute of Medicine of the National Academy of Sciences. He has received numerous awards including the AHA Scientific Councils Distinguished Achievement Award and the Centrum Center For Nutrition Science Award of the American Society for Nutrition, and he is listed in Who’s Who in America and the World. Dr. Krauss is on the editorial boards of a number of journals, and is Associate Editor of Obesity. Dr. Krauss has published nearly 400 research articles and reviews on genetic, dietary, and drug effects on plasma lipoproteins and coronary artery disease. In recent years Dr. Krauss’ work has focused on interactions of genes with dietary and drug treatments that affect metabolic phenotypes and cardiovascular disease risk.


Penny Kris-Etherton, PhD, Rd
Pennsylvania State University
University Park, PA
Term: 2016-2020

Dr. Penny Kris-Etherton, a world-renowned expert and national leader in food and nutrition, is Distinguished Professor of Nutrition in the Department of Nutritional Sciences at the Pennsylvania State University, where she has been on the faculty since 1979. Her research expertise is cardiovascular nutrition. She conducts controlled clinical nutrition studies designed to evaluate the role of diet on risk factors for cardiovascular disease (CVD). These studies have evaluated established and emerging CVD risk factors including lipids, lipoproteins, blood pressure, inflammatory markers, measures of oxidative stress and adhesion molecules. She and her colleagues have studied many different populations, including healthy participants, overweight and obese individuals, as well as persons at risk for CVD. Her research integrates clinical and basic research to evaluate underlying mechanisms that account for the diet-induced clinical responses, including the molecular mechanisms of action. Penny embraces interdisciplinary research that integrates the expertise of many colleagues.  

Penny has served on many national committees that have established dietary guidelines and recommendations. She served on the 2nd Adult Treatment Panel of the National Cholesterol Education Program, the Dietary Reference Intakes for Macronutrients Committee of the National Academies, the Health and Human Services/United States Department of Agriculture (USDA) Dietary Guidelines Advisory Committee 2005, and the Nutrition Committee of the American Heart Association that published diet and lifestyle recommendations for the prevention and treatment of CVD. She is a Fellow of the American Heart Association, the National Lipid Association, and the American Society for Nutrition. Her many awards include the 2014 Ralph Homan Lifetime Achievement Award from the American Oil Chemist’s Society, Marjorie Hulsizer Copher Award from the American Dietetic Association in 2007 (ADA), the Elaine Monsen Research Award from the American Dietetic Association Foundation (2005), Foundation Award for Excellence in Research by the ADA (1998), and the Lederle Award for Human Nutrition Research awarded by the American Society for Nutritional Sciences (1991), and is listed as a U.S. News & World Report best diet expert.

Sidney C Smith, Jr., MD
University of North Carolina School of Medicine
Chapel Hill, NC
Term: 2016-2020

Dr. Smith received his medical degree from Yale Medical School and completed his medical internship, residency, and cardiology fellowship at the Peter Bent Brigham (now Brigham and Women’s) Hospital/Harvard Medical School in Boston, MA. Dr. Smith is a past president of the American Heart Association (AHA) and the World Heart Federation (WHF).  Among his many honors include the AHA Physician of the Year Award, AHA Distinguished National Leadership Award, AHA Gold Heart Award, AHA Eugene Drake Award and the NHLBI/NIH Award of Special Recognition. Dr. Smith has authored or co-authored more than 350 published papers and chapters and has served on the editorial boards for the Journal of Cardiovascular Medicine, Journal of Clinical and Experimental Cardiology, Journal of the American College of Cardiology and Circulation. Each year since 1998, he has been elected to Best Doctors in America.

Nannete K WengerNanette K Wenger, MD
Emory University School of Medicine
Atlanta, GA
Term: 2016-2020

Dr. Wenger is Professor of Medicine in the Division of Cardiology at the Emory University School of Medicine. She is a Consultant to the Emory Heart and Vascular Center. Coronary heart disease in women is one of Dr. Wenger’s major clinical and research interests.  She chaired the U.S. National Heart, Lung, and Blood Institute Conference on Cardiovascular Health and Disease in Women.  Dr. Wenger has expertise in cardiac rehabilitation.  She chaired the World Health Organization Expert Committee on Rehabilitation after Cardiovascular Disease, and co-chaired the Guideline Panel on Cardiac Rehabilitation for the U.S. Agency for Health Care Policy and Research.  Dr. Wenger has had a longstanding interest in geriatric cardiology,  is a Past President of the Society of Geriatric Cardiology and was Editor-in-Chief of the American Journal of Geriatric Cardiology for more than 15 years.

In 2012, Dr. Wenger received the Charles R. Hatcher, Jr., MD, Award for Excellence in Public Health from Emory University; and was honored in 2013 by the establishment of the J. Willis Hurst, R. Bruce Logue, and Nanette K. Wenger Cardiovascular Society for Emory Cardiology Trainee Alumni. In 2013, she received the Inaugural Distinguished Mentor Award of the American College of Cardiology and the Arnall Patz Lifetime Achievement Award of the Emory University School of Medicine Medical Alumni Association. The American Society of Preventive Cardiology honored Dr. Wenger by naming an annual Nanette K. Wenger Distinguished Lecture focusing on cardiovascular prevention in women (2014). 

In 2015, she was awarded the Inaugural Bernadine Healy Leadership in Women’s CV Disease Award, American College of Cardiology.